|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Capitalization1 |
83 067 | 116 723 | 141 805 | 238 892 | 266 852 | 77 690 | - | - |
Enterprise Value (EV)1 |
86 744 | 123 288 | 151 546 | 246 995 | 276 217 | 87 214 | 86 842 | 85 768 |
P/E ratio |
154x | 99,9x | 78,3x | 88,9x | 53,6x | 16,1x | 14,4x | 12,0x |
Yield |
- | - | - | - | - | - | - | - |
Capitalization / Revenue |
7,10x | 7,39x | 7,04x | 9,56x | 8,99x | 2,40x | 2,19x | 2,00x |
EV / Revenue |
7,42x | 7,81x | 7,52x | 9,88x | 9,30x | 2,70x | 2,45x | 2,21x |
EV / EBITDA |
79,4x | 61,4x | 48,7x | 48,3x | 40,6x | 12,3x | 11,0x | 9,19x |
Price to Book |
23,1x | 22,2x | 19,3x | 22,2x | 17,3x | 3,91x | 3,17x | 2,64x |
Nbr of stocks (in thousands) |
432 731 | 436 085 | 438 251 | 441 795 | 442 952 | 444 274 | - | - |
Reference price (USD) |
192 | 268 | 324 | 541 | 602 | 175 | 175 | 175 |
Announcement Date |
01/22/2018 | 01/17/2019 | 01/21/2020 | 01/19/2021 | 01/20/2022 | - | - | - |
1 USD in Million |
|
|
Income Statement Evolution (Annual data) |
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net sales1 |
11 693 | 15 794 | 20 156 | 24 996 | 29 698 | 32 349 | 35 437 | 38 868 |
EBITDA1 |
1 093 | 2 009 | 3 113 | 5 116 | 6 806 | 7 071 | 7 892 | 9 329 |
Operating profit (EBIT)1 |
839 | 1 605 | 2 604 | 4 585 | 6 195 | 6 346 | 7 247 | 8 554 |
Operating Margin |
7,17% | 10,2% | 12,9% | 18,3% | 20,9% | 19,6% | 20,5% | 22,0% |
Pre-Tax Profit (EBT)1 |
485 | 1 226 | 2 062 | 3 199 | 5 840 | 5 909 | 6 551 | 7 944 |
Net income1 |
559 | 1 211 | 1 867 | 2 761 | 5 116 | 4 911 | 5 505 | 6 637 |
Net margin |
4,78% | 7,67% | 9,26% | 11,0% | 17,2% | 15,2% | 15,5% | 17,1% |
EPS2 |
1,25 | 2,68 | 4,13 | 6,08 | 11,2 | 10,9 | 12,2 | 14,5 |
Dividend per Share2 |
- | - | - | - | - | - | - | - |
Announcement Date |
01/22/2018 | 01/17/2019 | 01/21/2020 | 01/19/2021 | 01/20/2022 | - | - | - |
1 USD in Million 2 USD |
|
|
Income Statement Evolution (Quarterly data) |
|
Fiscal Period: December
|
2019 Q4 |
2020 Q1 |
2020 Q2 |
2020 Q3 |
2020 Q4 |
2021 Q1 |
2021 Q2 |
2021 Q3 |
2021 Q4 |
2022 Q1 |
2022 Q2 |
2022 Q3 |
2022 Q4 |
2023 Q1 |
2023 Q2 |
Net sales1 |
5 467 | 5 768 | 6 148 | 6 436 | 6 644 | 7 163 | 7 342 | 7 483 | 7 709 | 7 868 | 8 049 | 8 121 | 8 300 | 8 488 | 8 692 |
EBITDA1 |
586 | 1 084 | 1 489 | 1 450 | 1 094 | 2 103 | 1 988 | 1 921 | 795 | 2 165 | 1 889 | 1 801 | 1 204 | 2 043 | 2 080 |
Operating profit (EBIT)1 |
459 | 958 | 1 358 | 1 315 | 954 | 1 960 | 1 848 | 1 755 | 632 | 1 972 | 1 729 | 1 637 | 1 002 | 1 887 | 1 897 |
Operating Margin |
8,39% | 16,6% | 22,1% | 20,4% | 14,4% | 27,4% | 25,2% | 23,5% | 8,19% | 25,1% | 21,5% | 20,2% | 12,1% | 22,2% | 21,8% |
Pre-Tax Profit (EBT)1 |
149 | 796 | 1 036 | 861 | 506 | 2 035 | 1 594 | 1 661 | 551 | 1 980 | 1 591 | 1 480 | 848 | 1 774 | 1 743 |
Net income1 |
587 | 709 | 720 | 790 | 542 | 1 707 | 1 353 | 1 449 | 607 | 1 597 | 1 336 | 1 243 | 719 | 1 424 | 1 427 |
Net margin |
10,7% | 12,3% | 11,7% | 12,3% | 8,16% | 23,8% | 18,4% | 19,4% | 7,88% | 20,3% | 16,6% | 15,3% | 8,66% | 16,8% | 16,4% |
EPS2 |
1,30 | 1,57 | 1,59 | 1,74 | 1,19 | 3,75 | 2,97 | 3,19 | 1,33 | 3,53 | 2,95 | 2,75 | 1,59 | 3,23 | 3,21 |
Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date |
01/21/2020 | 04/21/2020 | 07/16/2020 | 10/20/2020 | 01/19/2021 | 04/20/2021 | 07/20/2021 | 10/19/2021 | 01/20/2022 | 04/19/2022 | - | - | - | - | - |
1 USD in Million 2 USD |
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net Debt1 |
3 677 | 6 566 | 9 741 | 8 103 | 9 365 | 9 524 | 9 152 | 8 078 |
Net Cash position1 |
- | - | - | - | - | - | - | - |
Leverage (Debt / EBITDA) |
3,36x | 3,27x | 3,13x | 1,58x | 1,38x | 1,35x | 1,16x | 0,87x |
Free Cash Flow1 |
-2 020 | -3 020 | -3 274 | 1 922 | -159 | 694 | 1 947 | 3 026 |
ROE (Net Profit / Equities) |
17,9% | 27,5% | 29,1% | 29,6% | 38,0% | 27,2% | 24,4% | 23,5% |
Shareholders' equity1 |
3 131 | 4 410 | 6 410 | 9 324 | 13 457 | 18 047 | 22 530 | 28 248 |
ROA (Net Profit / Asset) |
3,43% | 5,38% | 6,23% | 7,54% | 12,2% | 10,3% | 11,4% | 11,1% |
Assets1 |
16 300 | 22 494 | 29 975 | 36 628 | 41 933 | 47 745 | 48 317 | 60 060 |
Book Value Per Share2 |
8,29 | 12,0 | 16,8 | 24,4 | 34,8 | 44,8 | 55,1 | 66,3 |
Cash Flow per Share2 |
-4,00 | -5,94 | -6,39 | 5,34 | 0,86 | 1,65 | 3,39 | 6,54 |
Capex1 |
173 | 174 | 253 | 498 | 525 | 511 | 551 | 598 |
Capex / Sales |
1,48% | 1,10% | 1,26% | 1,99% | 1,77% | 1,58% | 1,56% | 1,54% |
Announcement Date |
01/22/2018 | 01/17/2019 | 01/21/2020 | 01/19/2021 | 01/20/2022 | - | - | - |
1 USD in Million 2 USD |
|
| |
|
|
Factbox-Companies offering abortion travel benefits to U.S. workers |
Capitalization (USD) |
77 690 168 149 |
Net sales (USD) |
29 697 844 000 |
Number of employees |
11 300 |
Sales / Employee (USD) |
2 628 128 |
Free-Float |
98,2% |
Free-Float capitalization (USD) |
76 262 583 825 |
Avg. Exchange 20 sessions (USD) |
1 703 215 152 |
Average Daily Capital Traded |
2,19% |
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
|